Results 241 to 250 of about 119,184 (308)

Novel Long-Read Sequencing Method for Characterisation of Hepatitis B Transcripts Show High Expression of Chimeric HBV/Human RNA. [PDF]

Liver Int
Stenbäck JB, Ringlander J, Andersson M, Thomsen JHD, Abrahamsson S, Rydell GE, Lindh M.   +6 more
europepmc   +1 more source

Innate Immune Activation Is a Strong Suppressor of CCL22 and Impedes Regulatory T Cell–Dendritic Cell Interaction

Immunology, EarlyView.
During homeostasis, CCL22 is secreted by dendritic cells (DC), which mediate contacts between regulatory T cells (Treg) and DC to maintain immune balance. Activation of innate immunity via microbes or pattern recognition receptor (PRR) agonists induces the secretion of several soluble factors (e.g., type I and II interferons, IL‐10), which mediate ...
Ignazio Piseddu, Jan Gärtig, Stephan Eiber, Stefan Moder, Raffael Thaler, Matthias Thaler, Juliane Gruen, Marlies Vornhülz, Kevin Bahner, Luana Messa, Benjamin Kühnemuth, Jennifer Müller, Konstantin Schnell, Antonia Beimert, Carolin Perleberg, Natascha Röhrle, Maximilian Martin Ludwig Knott, Linda Hammann, Vanessa Wittmann, Patrick Layritz, Moritz Rapp, Carole Bourquin, Julia Mayerle, Stefan Endres, David Anz   +24 more
wiley   +1 more source

Hepatitis B "e" antigen: a review.

Indian journal of pathology & microbiology, 1979
S S, Kelkar, R V, Kamat
openaire   +1 more source

Benefit of immune checkpoint inhibitors as adjuvant treatment for acral melanomas

Journal of the European Academy of Dermatology and Venereology, EarlyView.
When questioning the effectiveness of adjuvant immunotherapy for acral melanomas, we found no clinical benefit to the adjuvant proposal, despite the maintenance of adverse effects. Abstract Background Solar factors play no role in the development of acral melanoma (AM). AM is characterized by low cumulative solar damage (low CSD).
Damien Sanogo, Romain Levard, Julie Cassecuel, Amir Khammari, Gaelle Quereux, Florent Grange, Henri Montaudié, Florence Brunet‐Possenti, Justine Lavaud, Marie‐Thérèse Leccia, Géraldine Jeudy, Anne Dompmartin, Brigitte Dreno, Jean‐Matthieu L’Orphelin   +13 more
wiley   +1 more source

Autoantibodies in the follow-up of autoimmune hepatitis. [PDF]

J Transl Autoimmun
Nagy G, Bencze D, Demeter S, Pénzes-Daku K, Szabó L, Tóth B, Földesi R, Papp M, Antal-Szalmás P.   +8 more
europepmc   +1 more source

Parasitology [PDF]

, 2005
Cox, F, Despommier, D, Gillespie, S, Wakelin, D   +3 more
core  

Diagnostic performance of four hepatitis-B surface antigen conformité Européenne (CE) marked and one WHO prequalified rapid diagnostic tests in Uganda. [PDF]

PLoS One
Baliruno LN, Kato CD, Nakigozi H, Mujuzi H, Seremba E.   +4 more
europepmc   +1 more source

Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design. [PDF]

Nat Commun
He L, Lee YZ, Zhang YN, Newby ML, Janus BM, Gonzalez FG, Ward G, DesRoberts C, Hung SH, Giang E, Allen JD, Kulakova L, Toth EA, Fuerst TR, Law M, Ofek G, Crispin M, Zhu J.   +17 more
europepmc   +1 more source

Seroprevalence and Determinants of Hepatitis B and C Viral Infections Among Pregnant Women Attending Debark General Hospital, Northwest Ethiopia. [PDF]

Biomed Res Int
Alula GA, Tesema S.
europepmc   +1 more source

Combined HBsAg and anti-HBc testing is required to estimate hepatitis B virus seroprevalence in a low-endemic country: findings from a nationwide population-based serosurvey, Belgium, 2020. [PDF]

Euro Surveill
Furquim d'Almeida A, Ho E, Schüttler C, Beutels P, Hens N, Dudareva S, Van Damme P, Theeten H, Vanwolleghem T.   +8 more
europepmc   +1 more source